Loading...
Price History
Market Data
| Market Cap | 4.47B |
| P/E Ratio | 58.24 |
| P/B Ratio | 7.38 |
| EPS | 0.27 |
| Dividend Yield | - |
| D/E Ratio | 4.38 |
| Current Ratio | 2.46 |
| Currency | USD |
Key Financial Metrics
1.16B
Revenue
77.95M
Net Income
0.27
EPS (Diluted)
246.57M
Free Cash Flow
Profitability
Gross Margin
55.5%
Operating Margin
-
Net Profit Margin
6.7%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
2.4%
Return on Equity (ROE)
12.9%
Dividend Yield
-
EPS
0.27
Financial Health
Total Assets
3.26B
Total Debt
2.14B
Debt to Equity
4.38x
Current Ratio
2.46
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Net Value:
-610.80M
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | BROADVIEW HEIGHTS, OH |
| Fiscal Year | 2025 |
Peers
DAVITA INC
DVA
12.54B
P/E: --
12.54B
P/E: --
DAVITA INC.
DVA
12.54B
P/E: --
2.01B
P/E: 142.9
PROGYNY, INC.
PGNY
1.47B
P/E: 40.7
860.49M
P/E: --
463.98M
P/E: --
349.63M
P/E: 25.0
Quick Links
Financial Statistics
Valuation
Market Cap$4.47B
P/E Ratio (TTM)58.2
Price to Book7.38
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin55.5%
Operating Margin-
Net Margin6.7%
ROE12.9%
ROA2.4%
Leverage & Liquidity
Debt to Equity4.38
Current Ratio2.46
Total Debt$2.14B
Total Assets$3.26B
Stockholders' Equity$606.03M
Income Statement (FY 2025)
Revenue$1.16B
Gross Profit$645.53M
Operating Income-
Net Income$77.95M
EPS (Diluted)$0.27
Cash Flow (FY 2025)
Free Cash Flow$246.57M
Cash & Equivalents$344.62M
Revenue Growth5.7%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 9100 SOUTH HILLS BLVD, SUITE 300 BROADVIEW HEIGHTS, OH 44147 |
| Phone | 440-262-1410 |
| Incorporated | DE, US |
| EIN | 473531161 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 284.39M |
| Stockholders' Equity | $606.03M |
| Cash & Equivalents | $344.62M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-05
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-05-05
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-08
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-08
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-08
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-04-08
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-10
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
424B7
Prospectus (Rule 424b7)
Prospectus filed under Rule 424(b)(7)
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-04
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | SOTERA HEALTH CO |
| Ticker | SHC |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | BROADVIEW HEIGHTS, OH |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 4.47B |
| Revenue | 1.16B |
| Net Income | 77.95M |
| P/E Ratio | 58.24 |
| EPS | 0.27 |
| Net Margin | 6.7% |
| ROE | 12.9% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...